Mia's Feed
Medical News & Research

Updated Guidelines Emphasize Asking Diabetic Women About Pregnancy Intentions at Every Healthcare Visit

Updated Guidelines Emphasize Asking Diabetic Women About Pregnancy Intentions at Every Healthcare Visit

Share this article

New guidelines recommend healthcare providers routinely discuss pregnancy intentions with women managing diabetes during every medical visit to improve preconception care and reduce risks.

2 min read

Recent guidelines underscore the importance for healthcare providers to routinely inquire about reproductive goals of women with diabetes during each medical encounter. This proactive approach aims to facilitate proper preconception planning, reducing risks such as miscarriage and birth defects among women managing diabetes before pregnancy.

As part of comprehensive diabetes care, physicians are encouraged to discuss family planning, pregnancy timing, and contraception to ensure women are fully informed and prepared for pregnancy when ready. This initiative responds to the rising prevalence of diabetes in women of reproductive age, which often leads to inadequate preconception care.

The guidelines recommend that clinicians ask all women of childbearing age about their desire to conceive at every visit, whether related to their diabetes management or general health. For pregnant women with diabetes, early delivery—preferably before 39 weeks—is advised if risks associated with continuing pregnancy outweigh those of early birth. Additionally, certain medications like GLP-1 weight-loss drugs should be discontinued prior to conception, and metformin use during pregnancy should be carefully evaluated, especially in women already on insulin.

Innovations in insulin delivery, such as hybrid closed-loop systems with continuous glucose monitoring, are encouraged for pregnant women with type 1 diabetes to optimize glucose control. Furthermore, ongoing family planning and contraception use are critical until women are ready to conceive.

These recommendations are supported by substantial evidence from clinical trials and issued jointly by the Endocrine Society and the European Society of Endocrinology, with backing from leading organizations like the American Diabetes Association and the American College of Obstetricians and Gynecologists. Overall, emphasizing reproductive discussions at every healthcare visit aims to improve pregnancy outcomes and support women with diabetes in their family planning decisions.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Federal Court Blocks Effort to Cut Medicaid Funding for Planned Parenthood

A federal court has temporarily blocked the federal government from cutting Medicaid funding to Planned Parenthood clinics nationwide, ensuring continued access to essential reproductive health services amidst ongoing legal challenges.

Study Finds Higher Prevalence of Rare Neuroinflammatory Disease in Old Order Amish Community

Research reveals that a rare neuroinflammatory disease linked to CFI deficiency is over 4,500 times more common in the Old Order Amish community, emphasizing the importance of targeted genetic screening and personalized treatment approaches.

Low Treatment Rates for Alcohol Use Disorder in Cancer Survivors Highlight Systemic Gaps

Cancer survivors in the U.S. are receiving treatment for alcohol use disorder at very low rates, with only 14.3% initiating treatment within a year of diagnosis. Systemic barriers and stigma contribute to this gap, underscoring the need for improved screening and care.

Enhancing Mitochondrial Function and Platelet Production through Potassium Regulation

Recent research uncovers how potassium channel KCNN4 influences mitochondrial health and enhances platelet production, offering promising avenues for transfusion medicine and thrombocytopenia treatments.